Companies / Amneal Pharmaceuticals, Inc. / Activity
Activity — Amneal Pharmaceuticals, Inc.
106 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2025 as of | Norges Bank 13F manager | New | Common stock | $11.21M | +890K | 889,500 0.28% of shares | medium |
| Q1 2026 as of | Norges Bank 13F manager | Exit | Common stock | $-11.21M | -890K -100.00% | 0 | medium |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Trim | Common stock | $-11.71M | -942K -35.39% | 1,719,954 0.54% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common stock | $-37.17M | -3.0M -89.00% | 369,733 0.12% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $56.20M | +3.2M +78.98% | 7,356,977 2.30% of shares | high |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $212.28M | +12.3M +85.77% | 26,562,093 8.32% of shares | high |